Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nurix Therapeutics (NRIX) Asset Utilization Ratio (2020 - 2026)

Nurix Therapeutics (NRIX) has disclosed Asset Utilization Ratio for 7 consecutive years, with 0.04 as the latest value for Q1 2026.

  • Quarterly Asset Utilization Ratio fell 55.22% to 0.04 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.04 through Feb 2026, down 55.22% year-over-year, with the annual reading at 0.12 for FY2025, 16.24% up from the prior year.
  • Asset Utilization Ratio for Q1 2026 was 0.04 at Nurix Therapeutics, down from 0.07 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.24 in Q1 2024, with the low at 0.04 in Q1 2026.
  • Average Asset Utilization Ratio over 5 years is 0.12, with a median of 0.11 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio surged 163.05% in 2023, then crashed 59.39% in 2025.
  • Over 5 years, Asset Utilization Ratio stood at 0.09 in 2022, then soared by 163.05% to 0.23 in 2023, then crashed by 55.35% to 0.1 in 2024, then plummeted by 34.05% to 0.07 in 2025, then plummeted by 35.56% to 0.04 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.04, 0.07, and 0.11 for Q1 2026, Q4 2025, and Q3 2025 respectively.